DZD-9008 shows antitumor activity in NSCLC patients with EGFR exon20 insertion mutations June 9, 2021
Early phase II results presented for ponatinib plus blinatumomab combination in Ph+ ALL patients June 9, 2021
Phase Ib data indicate ST-617 can reduce severity of OM in patients receiving chemoradiation June 9, 2021
RSS